Bengaluru cafe brawl: Nalapad urged his friends to kill me, claims Vidwath

Mangaluru, Mar 27: Nine throat swab samples that were sent for testing of the coronavirus, have been declared as negative while samples of four more persons are currently being tested, official sources said on Friday.

Dakshina Kannada Deputy Commissioner Sindhu B. Rupesh said that 2,902 people are under home quarantine in the district as of today while three were admitted to hospitals for observation.

Around 38,051 people have been inspected, so far, here in this district.

Kochi, Mar 9: A three-year old child has tested positive for the novel coronavirus, officials said in Kochi on Monday.

The child and its parents who had reached the Cochin International Airport Limited at 6 AM on March 7 from Italy were subjected to thermal screening at the universal surveillance system established, officials said.

Detecting symptoms of coronavirus in the child, they were immediately referred to the isolation ward of the Kalamassery Medical College Hospital, they said. The samples of the child sent for examination at the NiV lab at Alappuzha have tested positive for Coronavirus, they said.

The samples of the parents have also been sent for lab test, the officials added.

Five fresh coronavirus cases, including three who evaded screening on return from Italy, were reported in Kerala, prompting the government on Sunday to sound a renewed alert and warn action against those hiding travel history to affected nations.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.